| Literature DB >> 27057546 |
Marco Caimmi1, Elisa Visani2, Fabio Digiacomo3, Alessandro Scano4, Andrea Chiavenna4, Cristina Gramigna3, Lorenzo Molinari Tosatti4, Silvana Franceschetti2, Franco Molteni3, Ferruccio Panzica2.
Abstract
Although rehabilitation robotics seems to be a promising therapy in the rehabilitation of the upper limb in stroke patients, consensus is still lacking on its additive effects. Therefore, there is a need for determining the possible success of robotic interventions on selected patients, which in turn determine the necessity for new investigating instruments supporting the treatment decision-making process and customization. The objective of the work presented in this preliminary study was to verify that fully robot assistance would not affect the physiological oscillatory cortical activity related to a functional movement in healthy subjects. Further, the clinical results following the robotic treatment of a chronic stroke patient, who positively reacted to the robotic intervention, were analyzed and discussed. First results show that there is no difference in EEG activation pattern between assisted and no-assisted movement in healthy subjects. Even more importantly, the patient's pretreatment EEG activation pattern in no-assisted movement was completely altered, while it recovered to a quasi-physiological one in robot-assisted movement. The functional improvement following treatment was large. Using pretreatment EEG recording during robot-assisted movement might be a valid approach to assess the potential ability of the patient for recovering.Entities:
Mesh:
Year: 2016 PMID: 27057546 PMCID: PMC4739000 DOI: 10.1155/2016/7051340
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1The Mitsubishi Pa10-7 robot platform.
Figure 2The robot-assisted Hand-to-Mouth Movement.
Figure 3Mean alpha and beta ERD/ERS color maps in control subjects group during right hand active no-assisted movement (a), left hand active no-assisted movement (b), and right hand robot-assisted movement (c). ERD/ERS values reported are expressed as percent power change.
α-ERD, β-ERD, and β-ERS parameters on contralateral central electrode.
| Healthy subjects | ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Task A | −62.7 ± 21.4 | 1.5 ± 1.1 | −63.0 ± 16.7 | 1.2 ± 1.0 | 77.5 ± 38.4 | 3.7 ± 1.1 |
| Task B | −64.1 ± 28.3 | 1.2 ± 0.6 | −66.4 ± 15.8 | 1.1 ± 0.5 | 81.2 ± 38.6 | 3.3 ± 0.9 |
| Task C | −64.9 ± 20.0 | 2.3 ± 1.2 | −65.1 ± 11.9 | 2.4 ± 1.2 | 74.7 ± 31.2 | 5.5 ± 0.8 |
Figure 4ERD/ERS analysis on the patient. ((a1), (b1), and (c1)) Mean of EMG signals; ((a2), (b2), and (c2)) Alpha and beta ERD/ERS time courses in contralateral and ipsilateral central areas (upper panels) and ERD/ERS color maps during right (unaffected) hand active no-assisted movement (a), left (affected) hand active no-assisted movement (b), and left (affected) hand robot-assisted movement (c). ERD/ERS values reported are expressed as percent power change.
Patient's scores in the Fugl-Meyer Assessment and in the Manual Muscle Test.
| Scale | (max. score) | T0 | T1 | T2 | T3 |
|---|---|---|---|---|---|
| FMA (0–66) | |||||
| Section A (shoulder and elbow) | (36) | 17 | 23 | 30 | 35 |
| Section B (wrist) | (10) | 4 | 5 | 7 | 7 |
| Section C (hand) | (14) | 4 | 6 | 9 | 12 |
| Section D (coordination/velocity) | (6) | 4 | 5 | 5 | 5 |
|
| |||||
| Total score | (66) |
|
|
|
|
|
| |||||
| MMT Scale (0–15) | |||||
| Shoulder abduction | (5) | 4 | 4 | 5 | 5 |
| Elbow extension | (5) | 4 | 4 | 5 | 5 |
| Fingers extension | (5) | 1 | 1 | 1 | 3 |
|
| |||||
| Total score | (15) |
|
|
|
|
FMA: Fugl-Meyer Assessment, MMT: Manual Muscle Test, T0: at the baseline, T1: after one month of treatment, T2: at the end of the treatment, and T3: at one-year follow-up.